Found: 9
Select item for more details and to access through your institution.
Case Report on Deep Brain Stimulation Rescue After Suboptimal MR-Guided Focused Ultrasound Thalamotomy for Essential Tremor: A Tractography-Based Investigation.
- Published in:
- Frontiers in Human Neuroscience, 2020, v. 14, p. 1, doi. 10.3389/fnhum.2020.00191
- By:
- Publication type:
- Article
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.
- Published in:
- EMBO Journal, 2004, v. 23, n. 20, p. 4061, doi. 10.1038/sj.emboj.7600402
- By:
- Publication type:
- Article
The negative role of cyclin G in ATM-dependent p53 activation.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5405, doi. 10.1038/sj.onc.1207693
- By:
- Publication type:
- Article
Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
- Published in:
- Nature Genetics, 2002, v. 31, n. 2, p. 190, doi. 10.1038/ng891
- By:
- Publication type:
- Article
The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 5, p. 406, doi. 10.1111/j.1600-0609.2012.01764.x
- By:
- Publication type:
- Article
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 4, p. 337, doi. 10.1111/j.1600-0609.2009.01403.x
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
- By:
- Publication type:
- Article
Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 3, p. 319, doi. 10.1111/j.1365-2141.2009.07852.x
- By:
- Publication type:
- Article
A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.06498
- By:
- Publication type:
- Article